We are live on !
Find out more
Hussman Strategic Advisors Portfolio holdings
AUM
$434M
Turnover
50.6%
1-Year Est. Return
19.64%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+19.64%
3 Year Est. Return
+41.56%
5 Year Est. Return
+34.45%
10 Year Est. Return
+261.65%
AUM
$434M
AUM Growth
-$28.5M
(-6.2%)
Cap. Flow
-$39M
Cap. Flow % of AUM
Cap. Flow %
-8.97%
Top 10 Holdings %
Top 10 Hldgs %
10.4%
Holding
334
New
66
Increased
40
Reduced
42
Closed
103
Avg Time Held
2
years
Top 10 Avg Time Held
0.1
years
Top 20 Avg Time Held
0.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$4.08M |
| 2 |
Ubiquiti
UI
|
+$3.96M |
| 3 |
Salesforce
CRM
|
+$3.69M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$3.57M |
| 5 |
Globus Medical
GMED
|
+$3.57M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$5.08M |
| 2 |
Sezzle
SEZL
|
+$3.99M |
| 3 |
Power Solutions International
PSIX
|
+$3.84M |
| 4 |
Qualys
QLYS
|
+$3.69M |
| 5 |
Progyny
PGNY
|
+$3.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.08% |
| 2 | Technology | 17.18% |
| 3 | Consumer Discretionary | 15.3% |
| 4 | Financials | 9.77% |
| 5 | Consumer Staples | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
PepsiCo
PEP
$189B
| $5.12M | 1.18% |
37,800
+27,300
| +260% | +$4.08M |
2021 Q2
20 quarters
|
|
|
2
Ubiquiti
UI
$36.1B
| $5.05M | 1.16% |
9,450
+5,250
| +125% | +$3.96M |
2025 Q1
5 quarters
|
|
3
Incyte
INCY
$23.7B
| $4.76M | 1.1% |
42,000
+10,500
| +33% | +$1.04M |
2024 Q4
6 quarters
|
|
4
Viasat
VSAT
$8.13B
| $4.72M | 1.09% |
52,500
-21,000
| -29% | -$1.39M |
2025 Q3
3 quarters
|
|
5
Neurocrine Biosciences
NBIX
$14.6B
| $4.6M | 1.06% |
27,300
+6,300
| +30% | +$935K |
2025 Q3
3 quarters
|
|
6
Biogen
BIIB
$37.5B
| $4.54M | 1.05% |
21,000
+14,700
| +233% | +$2.81M |
2026 Q1
1 quarter
|
|
7
Hershey
HSY
$35.3B
| $4.42M | 1.02% |
25,200
+16,800
| +200% | +$3.17M |
2023 Q4
10 quarters
|
|
8
Cimpress
CMPR
$2B
| $4.27M | 0.98% |
42,000
+21,000
| +100% | +$1.87M |
2026 Q1
1 quarter
|
|
9
Ziff Davis
ZD
$1.99B
| $3.85M | 0.89% |
73,500
+21,000
| +40% | +$950K |
2026 Q1
1 quarter
|
|
10
United Natural Foods
UNFI
$2.85B
| $3.84M | 0.88% |
84,000
-21,000
| -20% | -$1.04M |
2024 Q4
6 quarters
|
|
11
Ulta Beauty
ULTA
$27.2B
| $3.79M | 0.87% |
8,400
+1,050
| +14% | +$533K |
2026 Q1
1 quarter
|
|
12
Campbell Soup
CPB
$6.34B
| $3.74M | 0.86% |
168,000
-42,000
| -20% | -$886K |
2020 Q1
25 quarters
|
|
13
General Mills
GIS
$18.8B
| $3.65M | 0.84% |
105,000
+42,000
| +67% | +$1.45M |
2019 Q2
28 quarters
|
|
14
Teradata
TDC
$3.18B
| $3.64M | 0.84% |
+105,000
| New | +$3.19M |
2026 Q2
0 quarters
|
|
15
Dollar General
DG
$30.7B
| $3.63M | 0.84% |
31,500
| – | – |
2025 Q3
3 quarters
|
|
16
American Eagle Outfitters
AEO
$3B
| $3.61M | 0.83% |
210,000
| – | – |
2026 Q1
1 quarter
|
|
17
PACS Group
PACS
$7.52B
| $3.58M | 0.83% |
+84,000
| New | +$3.02M |
2026 Q2
0 quarters
|
|
18
Aurinia Pharmaceuticals
AUPH
$2.31B
| $3.56M | 0.82% |
210,000
+126,000
| +150% | +$2.01M |
2025 Q1
5 quarters
|
|
19
Steven Madden
SHOO
$3.25B
| $3.54M | 0.81% |
84,000
| – | – |
2026 Q1
1 quarter
|
|
20
Provident Financial Services
PFS
$3.02B
| $3.48M | 0.8% |
+147,000
| New | +$3.3M |
2026 Q2
0 quarters
|
|
21
Protolabs
PRLB
$2.02B
| $3.42M | 0.79% |
42,000
-10,500
| -20% | -$739K |
2026 Q1
1 quarter
|
|
22
APA Corp
APA
$17.3B
| $3.42M | 0.79% |
105,000
| – | – |
2025 Q3
3 quarters
|
|
23
Newmont
NEM
$120B
| $3.42M | 0.79% |
36,600
+24,400
| +200% | +$2.66M |
2013 Q2
52 quarters
|
|
24
Barrick Mining
B
$63.6B
| $3.36M | 0.77% |
91,500
+61,000
| +200% | +$2.5M |
2013 Q2
52 quarters
|
|
25
Mercury Insurance
MCY
$5.91B
| $3.36M | 0.77% |
31,500
+10,500
| +50% | +$1.03M |
2026 Q1
1 quarter
|
|
Similar funds
NICM
DCM
CEI
Hussman Strategic Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Hussman Strategic Advisors held 334 positions worth $434M, down 6.2% from $463M the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Hussman Strategic Advisors withdrew a net $39M in Q2 2026, closing 103 positions and reducing 42 holdings. Its most notable exit was Corcept Therapeutics, an estimated $5.08M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Hussman Strategic Advisors opened a new position in Salesforce worth $3.29M.
- Hussman Strategic Advisors's largest Q2 2026 buy was Salesforce: 21,000 shares worth $3.29M.
- Hussman Strategic Advisors added most to PepsiCo in Q2 2026, an estimated $4.08M increase.
- Hussman Strategic Advisors's biggest Q2 2026 reduction was Concentrix, cutting an estimated $2.74M.
- Hussman Strategic Advisors fully exited Corcept Therapeutics in Q2 2026, selling an estimated $5.08M.
- Hussman Strategic Advisors's ten largest holdings make up 10% of its $434M portfolio in Q2 2026.
- Hussman Strategic Advisors opened 66 new positions and closed 103 in Q2 2026.
- Hussman Strategic Advisors's portfolio value fell 6.2% quarter-over-quarter to $434M.
Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.